BIODESIX, INC. Earnings Per Share, Basic and Diluted
BIODESIX, INC. (BDSX) reported Earnings Per Share, Basic and Diluted of -$0.40 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-04
- BIODESIX, INC. earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$0.40.
- BIODESIX, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.50.
- BIODESIX, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.49.
- BIODESIX, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.41.
- BIODESIX, INC. earnings per share, basic and diluted for fiscal 2021 was -$1.58.
- BIODESIX, INC. earnings per share, basic and diluted for fiscal 2020 was -$6.48.
- BIODESIX, INC. earnings per share, basic and diluted for fiscal 2019 was -$126.97.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | -$0.40 10-Q · filed 2022-08-04 | -$0.89 10-Q · filed 2022-08-04 | -$1.38 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.79 derived: net income ÷ weighted average shares · filed 2023-11-07 | |
| 2022-03-31 | -$0.50 10-Q · filed 2022-05-11 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.41 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.82 derived: net income ÷ weighted average shares · filed 2023-11-07 | |
| 2021-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$0.90 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.58 10-K · filed 2022-03-14 | |
| 2021-09-30 | -$0.41 10-Q · filed 2021-11-15 | -$0.82 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.09 10-Q · filed 2021-11-15 | -$2.72 derived: net income ÷ weighted average shares · filed 2023-03-06 | |
| 2021-06-30 | -$0.41 10-Q · filed 2022-08-04 | -$0.68 10-Q · filed 2022-08-04 | -$2.35 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$3.60 derived: net income ÷ weighted average shares · filed 2023-03-06 | |
| 2021-03-31 | -$0.41 10-Q · filed 2022-08-04 | -$0.26 10-Q · filed 2021-05-11 | -$2.02 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$3.60 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$5.49 derived: net income ÷ weighted average shares · filed 2023-03-06 |
| 2020-12-31 | -$2.08 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$5.04 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$8.76 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$6.48 10-K · filed 2022-03-14 | |
| 2020-09-30 | -$31.93 10-Q · filed 2021-11-15 | -$62.00 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$99.69 10-Q · filed 2021-11-15 | -$123.26 derived: net income ÷ weighted average shares · filed 2021-11-15 | |
| 2020-06-30 | -$30.06 10-Q · filed 2021-08-10 | -$68.85 10-Q · filed 2021-08-10 | -$91.29 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$130.02 derived: net income ÷ weighted average shares · filed 2021-11-15 | |
| 2020-03-31 | -$37.18 10-Q · filed 2021-05-11 | -$61.25 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$100.12 derived: net income ÷ weighted average shares · filed 2021-11-15 | ||
| 2019-12-31 | -$24.26 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$62.87 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$126.97 10-K · filed 2021-03-16 | ||
| 2019-09-30 | -$39.35 10-Q · filed 2020-12-10 | -$103.87 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |